ArticleJournal of Cancer2020

Efficacy and Safety of Apatinib Combined with Etoposide in Patients with Recurrent Platinum-resistant Epithelial Ovarian Cancer: A Retrospective Study.

Qi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.